Sign in
Stories
Kuros Biosciences Advances MagnetOs Portfolio
Share
Accelus Strengthens Leadership with New ...
Bone Grafts and Substitutes Market Growt...
Growing Markets in Healthcare Technology
Artificial Disc Market Set for Rapid Exp...
Bioengineering Human Vein Implants Innov...
Curiteva Appoints Medical Device Veteran
Overview
API
Kuros Biosciences makes significant advancements with positive clinical trial results and FDA clearances for its MagnetOs portfolio, focusing on bone growth through innovative surface technology.
Ask a question
How might the positive clinical trial results impact the adoption of MagnetOs in the healthcare industry?
In what ways could the innovative surface technology employed by Kuros Biosciences influence future advancements in bone growth technology?
What potential implications do the FDA clearances have for the development and commercialization of MagnetOs products?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage